Our clients include world's top universities and pharmaceutical organizations
Celltrion
Friday, February 21, 2025
Celltrion Unveils New Post-Hoc Analyses of LIBERTY Studies at the 20th ECCO Congress Further Evaluating the Efficacy and Safety of Subcutaneous (SC) Infliximab
Verastem Oncology
Thursday, February 20, 2025
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
Dynavax Technologies
Thursday, February 20, 2025
Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
Cell
Wednesday, February 19, 2025
Solute carriers: The gatekeepers of metabolism
Cell
Wednesday, February 19, 2025
Cellular responses to RNA damage
Cell
Wednesday, February 19, 2025
Advances in the study and treatment of genetic cardiomyopathies
Cell
Wednesday, February 19, 2025
Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin
Incyte
Thursday, February 20, 2025
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
Dare Bioscience
Thursday, February 20, 2025
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
Phio Pharmaceuticals
Thursday, February 20, 2025
Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors
Cell
Wednesday, February 19, 2025
Passage of the HIV capsid cracks the nuclear pore
Cell
Wednesday, February 19, 2025
Squeeze pumping of lipids and insecticides by ABCH transporter
Cell
Wednesday, February 19, 2025
Plasmodesmata act as unconventional membrane contact sites regulating intercellular molecular exchange in plants
Cell
Wednesday, February 19, 2025
A biophysical basis for the spreading behavior and limited diffusion of Xist
Immunic
Thursday, February 20, 2025
– Dose-Dependent Increase of Endogenous GLP-1 Levels Observed in Post Hoc Analysis of Patients From Phase
Telix Pharmaceuticals
Thursday, February 20, 2025
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
Zealand Pharma
Thursday, February 20, 2025
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
Swedish Orphan Biovitrum
Thursday, February 20, 2025
EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN
Cell
Wednesday, February 19, 2025
Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation
Cell
Wednesday, February 19, 2025
Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes
Cell
Wednesday, February 19, 2025
Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
Cell
Wednesday, February 19, 2025
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women
Cel-Sci
Thursday, February 20, 2025
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
Zealand Pharma
Thursday, February 20, 2025
Zealand Pharma Announces Financial Results for the Full Year 2024
Xenon Pharmaceuticals
Thursday, February 20, 2025
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
VistaGen Therapeutics
Thursday, February 20, 2025
Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
Cell
Wednesday, February 19, 2025
Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease
Cell
Wednesday, February 19, 2025
Integration of 168,000 samples reveals global patterns of the human gut microbiome
Cell
Wednesday, February 19, 2025
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
Cell
Wednesday, February 19, 2025
Global organelle profiling reveals subcellular localization and remodeling at proteome scale
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.